A marker for Stevens-Johnson syndrome ...: ethnicity matters

被引:289
作者
Lonjou, C.
Thomas, L.
Borot, N.
Ledger, N.
de Toma, C.
LeLouet, H.
Graf, E.
Schumacher, M.
Hovnanian, A.
Mockenhaupt, M.
Roujeau, J. -C. [1 ]
机构
[1] Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France
[2] CHU Purpan, INSERM, U563, Toulouse, France
[3] Fdn Jean Dausset, Paris, France
[4] Hop Henri Mondor, Dept Pharmacovigilance, F-94010 Creteil, France
[5] Univ Hosp Freiburg, Inst Med Biometry & Informat, Freiburg, Germany
[6] Univ Hosp Freiburg, Dept Dermatol, Documentat Ctr Severe Skin React, Freiburg, Germany
关键词
Stevens-Johnson syndrome-toxic epidermal necrolysis; HLA; carbamazepine;
D O I
10.1038/sj.tpj.6500356
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe cutaneous adverse drug reactions, which can be caused by a certain number of specific drugs among which is carbamazepine, an antiepileptic agent. A very strong association of carbamazepine-induced SJS with HLA-B*1502 has recently been described in the Han Chinese population. Here in, we report preliminary results from a European study (RegiSCAR) of 12 carbamazepine-induced SJS/TEN cases (nine French and three German). Among these only four had a HLA-B*1502 allele. Remarkably, these four patients had an Asian ancestry, whereas the others did not as far as we have ascertained. This shows that although the HLA region may contain important genes for SJS, the HLA-B*1502 allele is not a universal marker for this disease and that ethnicity matters.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 16 条
[1]   Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes [J].
Azukizawa, H ;
Kosaka, H ;
Sano, S ;
Heath, WR ;
Takahashi, I ;
Gao, XH ;
Sumikawa, Y ;
Okabe, M ;
Yoshikawa, K ;
Itami, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (07) :1879-1888
[2]   A marker for Stevens-Johnson syndrome [J].
Chung, WH ;
Hung, SI ;
Hong, HS ;
Hsih, MS ;
Yang, LC ;
Ho, HC ;
Wu, JY ;
Chen, YT .
NATURE, 2004, 428 (6982) :486-486
[3]   Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis [J].
Fagot, JP ;
Mockenhaupt, M ;
Bouwes-Bavinck, JN ;
Naldi, L ;
Viboud, C ;
Roujeau, JC .
AIDS, 2001, 15 (14) :1843-1848
[4]  
GEER L, 1998, HLA 1998, P327
[5]   MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION [J].
GERMAIN, RN .
CELL, 1994, 76 (02) :287-299
[6]   Genetic variations in HLA-B region and hypersensitivity reactions to abacavir [J].
Hetherington, S ;
Hughes, AR ;
Mosteller, M ;
Shortino, D ;
Baker, KL ;
Spreen, W ;
Lai, E ;
Davies, K ;
Handley, A ;
Dow, DJ ;
Fling, ME ;
Stocum, M ;
Bowman, C ;
Thurmond, LM ;
Roses, AD .
LANCET, 2002, 359 (9312) :1121-1122
[7]   HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol [J].
Hung, SL ;
Chung, WH ;
Liou, LB ;
Chu, CC ;
Lin, M ;
Huang, HP ;
Lin, YL ;
Lan, JL ;
Yang, LC ;
Hong, HS ;
Chen, MJ ;
Lai, PC ;
Wu, MS ;
Chu, CY ;
Wang, KH ;
Chen, CH ;
Fann, CSJ ;
Wu, JY ;
Chen, YT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (11) :4134-4139
[8]  
MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103
[9]   Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir [J].
Mallal, S ;
Nolan, D ;
Witt, C ;
Masel, G ;
Martin, AM ;
Moore, C ;
Sayer, D ;
Castley, A ;
Mamotte, C ;
Maxwell, D ;
James, I ;
Christiansen, FT .
LANCET, 2002, 359 (9308) :727-732
[10]   Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells [J].
Nassif, A ;
Bensussan, A ;
Boumsell, L ;
Deniaud, A ;
Moslehi, H ;
Wolkenstein, P ;
Bagot, M ;
Roujeau, JC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (05) :1209-1215